The objective of this conference is to provide most recent concepts in the areas of genetics and epigenetics of various cancers and the application of AI in cancer diagnosis and treatment. With a focus on the most recent advancements, the conference features a diverse choice of presenters and speakers from renowned institutions and organizations in India and abroad. The two-day scientific convention fosters the development of enduring scientific communities and building research collaborations. In addition to the keynote addresses, the conference also features oral/poster presentations. Additionally, it provides an opportunity for networking with eminent scientists in the field.

The conference focuses on the transformative role of AI in cancer diagnosis and treatment. With the rise in biomedical data, AI enables early and accurate cancer detection through advanced imaging, supports informed therapeutic decisions, and accelerates drug discovery via data integration and predictive modeling. Machine learning helps identify disease patterns and predict treatment responses, paving the way for personalized therapy. Recent breakthroughs in AI-driven diagnostic tools, drug discovery and decision support will be featured in this conference.

Addressing the challenges in advancing next-generation cancer genomics research and effectively integrating the vast and complex cancer genomics datasets is another key focus of this conference. The event is expected to be of significant interest to cancer researchers, molecular biologists, and bioinformaticians who aim to incorporate the latest genetic and epigenetic discoveries into their cancer studies.